Tine Lottenburger

MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Merete Lund Hetland, B Ejbjerg, Søren Jacobsen et al. · Annals of the Rheumatic Diseases · 2008 · 366 citations

Medicine, Clinical Sciences, Immunology +17

Radiographic progression and remission rates in early rheumatoid arthritis – MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial

Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker et al. · Annals of the Rheumatic Diseases · 2010 · 188 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: An investigator‐initiated, multicenter, randomized, double‐blind, parallel‐group, placebo‐controlled study

Merete Lund Hetland, Kristian Stengaard‐Pedersen, Peter Junker et al. · Arthritis & Rheumatism · 2006 · 173 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study

Merete Lund Hetland, K. Stengaard‐Pedersen, Peter Junker et al. · Annals of the Rheumatic Diseases · 2007 · 124 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP

Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg et al. · Annals of the Rheumatic Diseases · 2012 · 93 citations

Medicine, Clinical Sciences, Pharmacotherapy +17